Asociatia Oncohelp

Clinical research here focuses on gastroenterology, especially inflammatory bowel disease such as Crohn’s disease and ulcerative colitis. These studies are designed to evaluate new treatment options, compare them with existing care, and better understand how they may improve symptom control and intestinal healing.

• Studies in Crohn’s disease and moderately to severely active Crohn’s disease are assessing whether targeted therapies can improve remission and endoscopic outcomes.
• Research in ulcerative colitis is examining new approaches to reduce inflammation and support clinical remission in adults with active disease.
• Some trials are also looking at histologic and endoscopic response to help clarify how well treatments work inside the digestive tract.

Overall, the site is contributing to treatment development for chronic digestive system diseases by testing therapies aimed at improving both symptoms and disease activity.

The oncology research at Asociatia Oncohelp includes trials for head and neck cancer and HER2-positive breast cancer. This work is focused on evaluating whether new or combined cancer therapies can extend disease control and improve outcomes for patients with advanced or hard-to-treat tumors.

• Trials in head and neck squamous cell carcinoma are studying treatment strategies after chemoradiation to see if they can improve cancer control.
• Research in HER2-positive breast cancer is comparing combination treatment options for people with locally advanced or metastatic disease.
• These studies aim to assess effectiveness and safety while exploring better ways to manage advanced neoplasms.

This area reflects a strong interest in developing more effective cancer treatments for patients with advanced oncology needs.